THE CHART · Marketing problems · Urgent care

Admen · GROWTH PARTNERS FOR HEALTHCARE OPERATORS
BY APPLICATION · ~6 / QUARTER D-01

DX / Differentials / URGENT CARE

D-01 — PATIENT ACQUISITION COST · URGENT CARE

Cost per new patient is climbing — urgent care

Cost per visit is climbing — and there is no published benchmark to check it against

PRESENTATION — WHAT THE OPERATOR SEES

Marketing spend divided by visits keeps rising. Nobody can say whether that is the market, the season, the agency or the payer mix, because the number moves for four different reasons at once. And there is no industry figure to compare against: no association, EMR vendor or claims aggregator publishes cost per visit, cost per visit acquired, or marketing spend as a percentage of revenue for urgent care. That gap is real and we state it plainly rather than manufacture a number.

DIFFERENTIAL — LIKELY CAUSES, MOST LIKELY FIRST

  1. 01

    The denominator moved — you are dividing by a seasonally depressed visit count

    Cost per visit is a ratio. Hold spend constant and the ratio swings by nearly 40% across the year purely from arrival seasonality.

    On an average day in July there are 14% fewer patients than baseline; in December there are 25% more — a 39-point peak-to-trough swing. Experity's live series shows the same thing at a point in time: 27 average daily visits per clinic on 6 May 2026, against a UCA annual average of 33.96 for 2025 and peaks in the mid-to-high 30s in early 2026.

    Practice Velocity study of more than 20,000,000 patient visits over five years, via JUCM Developing Data, 14 Dec 2016; Experity urgent care visit data page (updated 6 May 2026); Urgent Care Association urgent-care-data page

    NOT THIS IF — You are already comparing same-month year over year, or against a trailing twelve months, and the cost per visit still rises.

  2. 02

    Net revenue per visit fell while spend held — the economics worsened, not the acquisition

    Reimbursement per visit is set locally and moves without warning. The marketing ratio deteriorates even when the marketing did not change.

    National median commercial net revenue per visit is $163.91. States in the bottom quartile averaged $130.30 per visit; the top quartile averaged $221.72 — a 70% spread, with a state range of $112.90 to $299.38 and a standard deviation of about 22%. The authors conclude there is "no single national market rate for urgent care, but more than 50 local microeconomies."

    Experity EMR — 17,410,492 commercially insured visits, 1 Nov 2024 to 31 Oct 2025 — via JUCM Developing Data, "Commercial Reimbursement In Urgent Care" (Ayers), 30 Dec 2025. Experity customers, commercially insured visits only; excludes Medicare, Medicaid, workers' comp and self-pay

    NOT THIS IF — Your contracted rates, payer mix and acuity distribution are all unchanged over the period the ratio moved.

  3. 03

    Acuity mix drifted down, or global-rate exposure grew

    Under a level-based E/M schedule, revenue per visit is set by the code distribution. Under a global rate it is fixed regardless of complexity, so acuity stops being a lever at all and volume becomes the only one.

    Median allowed amounts at urgent care centers in 2023: 99202 $112 · 99203 $145 · 99204 $179 · 99205 $213. In 2023 CPT 99213 held first position, 99214 rose from third to second, and S9083 (the urgent care global fee) fell from second to third. The global fee itself varies by region: average allowed $110 Midwest · $152 South · $159 West · $167 Northeast. UCA reports that since 2019 more centers are being reimbursed on a global S9083 or fixed amount per visit regardless of complexity.

    FAIR Health, FH Healthcare Indicators & FH Medical Price Index 2025 white paper (figures 15 and 17) and 2024 edition (table 3); UCA 2023 Finance Benchmarking Report via UCA 2023 Industry White Paper, p.9

    NOT THIS IF — A majority of your visits are already paid at a global rate. Then acuity is irrelevant to revenue and the problem is contracted rate or volume.

  4. 04

    You are paying to acquire visits you already had

    In a 5-mile catchment saturated with alternatives, paid media captures a large share of people who were coming anyway — brand searchers and returning patients — and the ratio inflates without any new demand.

    52% of centers define their target market as 0–5 miles and 38% as 6–10 miles. 89.4% of the US population is already within a 20-minute drive of an urgent care center and 78.6% within 10 minutes. Return-visit behaviour is real but modest: the closest thing the vertical has to a lifetime-value numerator is an unattributed industry figure of 1.7–2.0 visits per patient per year, which we flag as having no named primary.

    UCA 2022 Operations Benchmarking Report, p.7 (n=1,035); DX Marketing via UCA Spring 2021 Benchmarking Report p.9, UCA Fast Facts 2022 and the UCA data page. The 1.7–2.0 figure appears in JUCM, 31 May 2022, with no named primary — treat as directional only

    NOT THIS IF — Your paid volume is already majority non-brand and majority first-visit patients in the record.

  5. 05

    Collections leakage is masquerading as acquisition cost

    The visit happened and the money did not arrive, or arrived late. Spend per collected dollar rises while spend per visit is unchanged. This is the vertical's own self-reported number-one revenue problem.

    More than 55% of respondents ranked registration errors preventing clean claims as the single largest revenue-cycle challenge. Meanwhile only 17% of patients complete registration paperwork online before the visit — 42% complete it with staff and 41% on a tablet onsite. With a credit card on file, 80% of patient responsibility on CPT 99204 is paid in the first month versus 60% without; 90% of the balance collects in 2 months versus 5; and 12-month bad-debt write-offs are 1% versus 4%.

    UCA 2023 Finance Benchmarking Report (via Solv provider blog, 29 Jan 2024); UCA 2022 Operations Benchmarking Report p.21 (n=1,055); Experity analysis of 392,699 comparable Blue Cross Blue Shield urgent care visits, 2024, via JUCM Developing Data, 27 Sep 2025

    NOT THIS IF — First-pass claim resolution is already high, days to bill is short, and patient balances collect inside two months.

HOW TO TELL THEM APART

How to tell these apart in your own numbers

Each of these is a measurement you can run yourself, without us.

01 · The denominator moved — you are dividing by a seasonally depressed visit count

Recompute cost per visit three ways: same-month year over year, against a rolling twelve-month visit total, and against a seasonally indexed expected volume built from your own three-year monthly curve. All three want the same input — cost per visit built from the ledger rather than from an ad platform's own reporting.

CONFIRMS IF

The rise disappears or shrinks materially under same-month and rolling-twelve comparison.

EXCLUDES IF

All three methods show the same upward slope. The seasonality is not the story.

02 · Net revenue per visit fell while spend held — the economics worsened, not the acquisition

Pull your own net revenue per commercially insured visit for a full 12-month window and place it against the published bands: $130.30 bottom quartile, $163.91 national median, $181.36 upper-middle, $221.72 top quartile. Then compare against your own prior 12 months.

CONFIRMS IF

Your NRV fell year over year, or sits below the band your state's rate environment supports, while spend was flat.

EXCLUDES IF

NRV is flat or rising. The deterioration is on the acquisition side, not the reimbursement side.

03 · Acuity mix drifted down, or global-rate exposure grew

Your own distribution across 99202–99205 and 99213/99214, plus the share of visits paid at a global S9083 or fixed per-visit rate. Track both quarter over quarter, and compare the rank order against FAIR Health's (99213 first, 99214 second, S9083 third in 2023).

CONFIRMS IF

The distribution shifted toward lower levels, or the global-rate share of visits grew. Under a global rate, revenue per visit is fixed no matter what your providers document.

EXCLUDES IF

The code distribution is stable and global-rate share is unchanged.

04 · You are paying to acquire visits you already had

Split paid-attributed visits two ways: by branded versus non-branded query, and by whether the patient has a prior visit in your own record. Do it for a full quarter.

CONFIRMS IF

A majority of paid-attributed visits are returning patients or arrived on a branded query. You are buying visits the sign and the map already earned.

EXCLUDES IF

Paid volume is predominantly first-visit patients on non-brand queries.

05 · Collections leakage is masquerading as acquisition cost

First-pass resolution rate, days to bill, days in AR, percentage of patient responsibility collected in month one, and 12-month bad-debt write-off percentage. Then the intake measurement behind them: what share of registrations begin before arrival.

CONFIRMS IF

Month-one patient collection sits near 60% rather than 80%, bad debt runs near 4% rather than 1%, and registration is overwhelmingly done in the lobby.

EXCLUDES IF

Collections are clean and fast. The cost is genuinely on the acquisition side.

WHAT RESOLVES EACH

What resolves this, and how you will know it resolved

The denominator moved — you are dividing by a seasonally depressed visit count Rx 04 · marketing attribution → Cheapest fix in the document. Build the seasonal index once from your own history and every subsequent cost-per-visit reading becomes interpretable. Nothing to buy and no campaign to change.
Net revenue per visit fell while spend held — the economics worsened, not the acquisition Rx 04 · marketing attribution → This is payer contracting, not marketing, and we say so. A 70% spread between top- and bottom-quartile states is structural — no campaign closes it. What reporting does is stop you spending against a ratio you have misdiagnosed.
Acuity mix drifted down, or global-rate exposure grew Rx 04 · marketing attribution → Documentation and coding sit with your clinical and RCM teams, not with an agency. Our job is to surface the drift in the same readout as the spend, so the two are never argued separately. Under a majority-global-rate contract, stop optimising acuity and optimise volume and mix instead.
You are paying to acquire visits you already had Rx 01 · patient acquisition → Brand-search reclamation and non-brand demand mapping inside the real 5-mile catchment. What does not work: buying wider radii to raise volume — 52% of the industry's catchment is under 5 miles and 89.4% of the country is already within a 20-minute drive of somebody's urgent care.
Collections leakage is masquerading as acquisition cost Rx 03 · patient conversion → Pre-arrival registration and card-on-file are the two documented levers, and both are intake work. The association's own members rank registration errors as their number-one revenue-cycle problem while 83% of intake still happens in the lobby. That is an operations gap, not a demand gap.

WHAT "RESOLVED" LOOKS LIKE — Net revenue per commercially insured visit, read alongside a seasonally indexed marketing cost per visit computed from your own trailing series

MEDIAN

$163.91 national median commercial net revenue per visit (Experity, 17,410,492 commercially insured visits, Nov 2024–Oct 2025). Bottom-quartile states $130.30; lower-middle $157.87; upper-middle $181.36.

TOP DECILE

No decile is published. The highest sourced band is the top quartile of states at $221.72, against a full state range of $112.90–$299.38. We will not extrapolate a decile that the source does not report.

TARGET

Move your NRV into the upper-middle band for your state's rate environment — around $181 — and hold marketing cost per visit flat against a seasonally indexed denominator. On cost per visit specifically there is no industry benchmark to hit: no association, EMR vendor or claims aggregator publishes one for urgent care. The only legitimate comparison is your own trailing twelve months.

Experity EMR via JUCM Developing Data, 30 Dec 2025. The absence of any published acquisition-cost benchmark is documented in the ADMEN source register and stated publicly on /sources/ and /benchmarks/

HOW THIS DIFFERS BY SCALE

How this differs by scale

Single site One center, one payer contract set, one seasonal curve. Cost per visit is dominated by the seasonal denominator and by a handful of contracts; a single bad contract renegotiation can move NRV more than a year of media work. Measure same-month or do not measure.
Group Several centers, usually one or two states. The NRV comparison becomes internal and diagnostic: if two sites under identical contracts show different NRV, the difference is acuity documentation or collections, not the market. That is the fastest read available at this scale.
Platform Multi-state. The 70% NRV spread between top- and bottom-quartile states means a blended network cost-per-visit ratio is close to uninterpretable. Every site must be scored against its own state's reimbursement band, or you will defund the sites doing the best operational work in the worst-paying markets.

OTHER PRESENTATIONS — URGENT CARE

A differential narrows the field. It does not replace the examination — that is what the six weeks are for. Every figure above is an industry reference range, not a client's numbers; those stay sealed. Sources are set out at /sources.

APPLY — 6 / QUARTER →